CYHB2500905 | 注射用绒促性素 | chorionic gonadotrophin | Lyophilized | Chemical Drugs | Supplementary Application | 2025-05-01 | | Guangdong Sunho Pharmaceutical Co Ltd | | | view |
CYHB2500902 | 注射用绒促性素 | chorionic gonadotrophin | Lyophilized | Chemical Drugs | Supplementary Application | 2025-05-01 | | Guangdong Sunho Pharmaceutical Co Ltd | | | view |
CYHB2500906 | 注射用绒促性素 | chorionic gonadotrophin | Lyophilized | Chemical Drugs | Supplementary Application | 2025-05-01 | | Guangdong Sunho Pharmaceutical Co Ltd | | | view |
CYHB2500903 | 注射用绒促性素 | chorionic gonadotrophin | Lyophilized | Chemical Drugs | Supplementary Application | 2025-05-01 | | Guangdong Sunho Pharmaceutical Co Ltd | | | view |
CYHB2500904 | 注射用绒促性素 | chorionic gonadotrophin | Lyophilized | Chemical Drugs | Supplementary Application | 2025-05-01 | | Guangdong Sunho Pharmaceutical Co Ltd | | | view |
JYSB2400238 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2024-11-08 | | Merck Europe BV;Merck Serono SpA | | | view |
JYSB2400235 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2024-10-22 | | Merck Europe BV;Merck Serono SpA | | | view |
CXSL2400176 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products(3.3) | New Drug Application | 2024-03-12 | | Suzhou Shengji Pharmaceutical Co Ltd | | | view |
JYSZ2300014 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | License Renew | 2023-03-28 | | Merck Europe BV;Merck Serono SpA;Merck Serono Co Ltd | | | view |
JYSB2200089 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2022-05-31 | | Merck Europe BV;Merck Serono SpA | | | view |
CYHB2200717 | 注射用绒促性素 | chorionic gonadotrophin | Lyophilized | Chemical Drugs | Supplementary Application | 2022-04-28 | | Shenyang EverBright Pharmaceutical Co Ltd;Wuhan Humanwell Pharmaceutical Co Ltd | | | view |
CYHB2101698 | 注射用绒促性素 | chorionic gonadotrophin | Lyophilized | Chemical Drugs(原6) | Supplementary Application | 2021-08-19 | | Jiangxi HAORAN BIO-PHARMA Co Ltd;Techpool BIO-PHARMA Co Ltd | | | view |
CYHB2101499 | 注射用绒促性素 | chorionic gonadotrophin | Lyophilized | Chemical Drugs(原6) | Supplementary Application | 2021-07-12 | | Jiangxi HAORAN BIO-PHARMA Co Ltd;Techpool BIO-PHARMA Co Ltd | | | view |
CYHB2101498 | 注射用绒促性素 | chorionic gonadotrophin | Lyophilized | Chemical Drugs(原6) | Supplementary Application | 2021-07-12 | | Jiangxi HAORAN BIO-PHARMA Co Ltd;Techpool BIO-PHARMA Co Ltd | | | view |
JYSB2000376 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2020-08-21 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck Europe BV;Merck Serono SpA | Filed | 2020-09-02 | view |
JYSB2000315 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2020-07-17 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck Europe BV;Merck Serono SpA | In Review | 2020-07-16 | view |
JYSB2000069 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2020-03-20 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck Europe BV;Merck Serono SpA | Certificate Issued | 2020-06-05 | view |
JYSB2000070 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2020-03-05 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck Europe BV;Merck Serono SpA | Filed | 2020-03-26 | view |
JYSB1900103 | 重组人绒促性素注射液 | Recombinant Human Choriogonadotropin alfa | Injection | Biological Products | Supplementary Application | 2019-05-05 | 默克雪兰诺有限公司 | Merck Serono Co Ltd;Merck Serono SpA;Merck Serono Europe Ltd | Filed | 2019-05-15 | view |
CXSS1900006 | 注射用重组人绒促性素 | Choriogonadotropin | Lyophilized | Biological Products(15) | New Drug Application | 2019-02-20 | 丽珠集团丽珠制药厂 | Livzon (GROUP) Pharmaceutical FACTORY;Livzon Mabpharm INC | In Review | 2019-02-19 | view |